ANDE vs NBIX · P/E 12, rev $5.72B vs P/E 45, rev $1.77B
The Andersons Inc (ANDE) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
The Andersons Inc (ANDE) is a food distribution company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ANDE revenue for 2026-06-30 was $5.72B. Net income was $89.8M. ANDE currently screens at market cap $1.31B and trailing P/E 12.1.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ANDE currently screens at market cap $1.31B and trailing P/E 12.1. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ANDE and NBIX stock pages for the full models.
Not investment advice.